Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
This report elaborates on the current development of the Oncolytic Virus Therapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Oncolytics Biotech
Amgen
TILT Biotherapeutics
Vyriad
Genelux Corporation
Transgene SA
Viralytics
Lokon Pharma
Targovax
Cold Genesys
PsiOxus Therapeutics
SillaJen Biotherapeutics
Oncolys BioPharma
Sorrento Therapeutics
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Application:
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Oncolytic Virus Therapy Industry Overview
-
1.1.1 Oncolytic Virus Therapy Market Scope and Market Segments
-
1.1.2 Oncolytic Virus Therapy Industry Characteristics
-
1.1.3 Global and China Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Oncolytic Virus Therapy Production Value and Growth Rate (2017-2028)
-
1.2 Global Oncolytic Virus Therapy Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Melanoma
-
1.2.2 Prostate Cancer
-
1.2.3 Breast Cancer
-
1.2.4 Ovarian Cancer
-
1.2.5 Others
-
1.3 Global Oncolytic Virus Therapy Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Melanoma
-
1.3.2 Prostate Cancer
-
1.3.3 Breast Cancer
-
1.3.4 Ovarian Cancer
-
1.3.5 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Oncolytic Virus Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Oncolytic Virus Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Oncolytic Virus Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Oncolytic Virus Therapy Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Oncolytic Virus Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Oncolytic Virus Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Oncolytic Virus Therapy Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Oncolytic Virus Therapy Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Oncolytic Virus Therapy Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Oncolytic Virus Therapy Industry Porter's Five Forces Model Analysis
-
2.2.3 Oncolytic Virus Therapy Industry PEST Analysis
-
2.3 Oncolytic Virus Therapy Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Oncolytic Virus Therapy Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Oncolytic Virus Therapy Industry
Chapter 3 Global and China Oncolytic Virus Therapy Market, by Manufacturer
-
3.1 Global and China Oncolytic Virus Therapy Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Oncolytic Virus Therapy Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Oncolytic Virus Therapy Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Oncolytic Virus Therapy Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Oncolytic Virus Therapy Market Top 3 Players
Chapter 4 Global and China Oncolytic Virus Therapy Market, by Type (2017-2028)
-
4.1 Oncolytic Virus Therapy Market Trend, by Type
-
4.2 Global Oncolytic Virus Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Oncolytic Virus Therapy Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Oncolytic Virus Therapy Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Oncolytic Virus Therapy Price Trend, by Type (2017-2028)
-
4.3 China Oncolytic Virus Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Oncolytic Virus Therapy Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Oncolytic Virus Therapy Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Oncolytic Virus Therapy Price Trend, by Type (2017-2028)
Chapter 5 Global and China Oncolytic Virus Therapy Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Oncolytic Virus Therapy Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Oncolytic Virus Therapy Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Oncolytic Virus Therapy Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Oncolytic Virus Therapy Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Oncolytic Virus Therapy Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Oncolytic Virus Therapy Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Oncolytic Virus Therapy Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Oncolytic Virus Therapy Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Oncolytic Virus Therapy Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Oncolytic Virus Therapy Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Oncolytic Virus Therapy Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Oncolytic Virus Therapy Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Oncolytic Virus Therapy Market Analysis
-
7.1 North America Oncolytic Virus Therapy Market, by Type
-
7.2 North America Oncolytic Virus Therapy Market, by Application
-
7.3 North America Oncolytic Virus Therapy Market Analysis and Forecast, by Country
-
7.3.1 United States Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Oncolytic Virus Therapy Market Analysis
-
8.1 Europe Oncolytic Virus Therapy Market, by Type
-
8.2 Europe Oncolytic Virus Therapy Market, by Application
-
8.3 Europe Oncolytic Virus Therapy Market Analysis and Forecast, by Country
-
8.3.1 Germany Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Oncolytic Virus Therapy Market Analysis
-
9.1 APAC Oncolytic Virus Therapy Market, by Type
-
9.2 APAC Oncolytic Virus Therapy Market, by Application
-
9.3 APAC Oncolytic Virus Therapy Market Analysis and Forecast, by Country
-
9.3.1 China Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Oncolytic Virus Therapy Market Analysis
-
10.1 Latin America, Middle East and Africa Oncolytic Virus Therapy Market, by Type
-
10.2 Latin America, Middle East and Africa Oncolytic Virus Therapy Market, by Application
-
10.3 Latin America, Middle East and Africa Oncolytic Virus Therapy Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Oncolytic Virus Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Oncolytic Virus Therapy Company Profiles
-
11.1 Oncolytics Biotech
-
11.1.1 Oncolytics Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Oncolytics Biotech Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.1.3 Oncolytics Biotech Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Amgen
-
11.2.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Amgen Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.2.3 Amgen Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 TILT Biotherapeutics
-
11.3.1 TILT Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 TILT Biotherapeutics Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.3.3 TILT Biotherapeutics Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Vyriad
-
11.4.1 Vyriad Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Vyriad Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.4.3 Vyriad Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Genelux Corporation
-
11.5.1 Genelux Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Genelux Corporation Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.5.3 Genelux Corporation Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Transgene SA
-
11.6.1 Transgene SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Transgene SA Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.6.3 Transgene SA Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Viralytics
-
11.7.1 Viralytics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Viralytics Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.7.3 Viralytics Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Lokon Pharma
-
11.8.1 Lokon Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Lokon Pharma Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.8.3 Lokon Pharma Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Targovax
-
11.9.1 Targovax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Targovax Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.9.3 Targovax Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Cold Genesys
-
11.10.1 Cold Genesys Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Cold Genesys Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.10.3 Cold Genesys Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 PsiOxus Therapeutics
-
11.11.1 PsiOxus Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 PsiOxus Therapeutics Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.11.3 PsiOxus Therapeutics Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 SillaJen Biotherapeutics
-
11.12.1 SillaJen Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.12.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Oncolys BioPharma
-
11.13.1 Oncolys BioPharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Oncolys BioPharma Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.13.3 Oncolys BioPharma Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Sorrento Therapeutics
-
11.14.1 Sorrento Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Sorrento Therapeutics Oncolytic Virus Therapy Product Profiles, Application and Specification
-
11.14.3 Sorrento Therapeutics Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Oncolytic Virus Therapy Industry Investment Prospect and Risk Assessment
-
12.1 Oncolytic Virus Therapy Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Oncolytic Virus Therapy Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure China Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Global Oncolytic Virus Therapy Production Value and Growth Rate (2017-2028)
-
Figure China Oncolytic Virus Therapy Production Value and Growth Rate (2017-2028)
-
Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Melanoma (2017-2028)
-
Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Prostate Cancer (2017-2028)
-
Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Breast Cancer (2017-2028)
-
Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Ovarian Cancer (2017-2028)
-
Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Melanoma (2017-2028)
-
Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Prostate Cancer (2017-2028)
-
Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Breast Cancer (2017-2028)
-
Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Ovarian Cancer (2017-2028)
-
Figure Global Oncolytic Virus Therapy Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Oncolytic Virus Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Oncolytic Virus Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Oncolytic Virus Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Oncolytic Virus Therapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Oncolytic Virus Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Oncolytic Virus Therapy Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Oncolytic Virus Therapy Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Oncolytic Virus Therapy Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Oncolytic Virus Therapy Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Oncolytic Virus Therapy Market Share, by Manufacturer in 2021
-
Figure Global and China Oncolytic Virus Therapy Market Share, by Manufacturer in 2022
-
Table Global Oncolytic Virus Therapy Sales Volume, by Type (2017-2028)
-
Table Global Oncolytic Virus Therapy Sales Volume Share, by Type (2017-2028)
-
Figure Global Oncolytic Virus Therapy Sales Volume Share, by Type (2017-2028)
-
Table Global Oncolytic Virus Therapy Sales Value, by Type (2017-2028)
-
Table Global Oncolytic Virus Therapy Sales Value Share, by Type (2017-2028)
-
Figure Global Oncolytic Virus Therapy Price Trend, by Type (2017-2028)
-
Table China Oncolytic Virus Therapy Sales Volume, by Type (2017-2028)
-
Table China Oncolytic Virus Therapy Sales Volume Share, by Type (2017-2028)
-
Figure China Oncolytic Virus Therapy Sales Volume Share, by Type (2017-2028)
-
Table China Oncolytic Virus Therapy Sales Value, by Type (2017-2028)
-
Table China Oncolytic Virus Therapy Sales Value Share, by Type (2017-2028)
-
Figure China Oncolytic Virus Therapy Price Trend, by Type (2017-2028)
-
Table Global Oncolytic Virus Therapy Sales Volume, by Application (2017-2028)
-
Table Global Oncolytic Virus Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Global Oncolytic Virus Therapy Sales Volume Share, by Application (2017-2028)
-
Table Global Oncolytic Virus Therapy Sales Value, by Application (2017-2028)
-
Table Global Oncolytic Virus Therapy Sales Value Share, by Application (2017-2028)
-
Figure Global Oncolytic Virus Therapy Sales Value Share, by Application (2017-2028)
-
Table China Oncolytic Virus Therapy Sales Volume, by Application (2017-2028)
-
Table China Oncolytic Virus Therapy Sales Volume Share, by Application (2017-2028)
-
Figure China Oncolytic Virus Therapy Sales Volume Share, by Application (2017-2028)
-
Table China Oncolytic Virus Therapy Sales Value, by Application (2017-2028)
-
Table China Oncolytic Virus Therapy Sales Value Share, by Application (2017-2028)
-
Figure China Oncolytic Virus Therapy Sales Value Share, by Application (2017-2028)
-
Figure China Oncolytic Virus Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure North America Oncolytic Virus Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Oncolytic Virus Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Oncolytic Virus Therapy Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Oncolytic Virus Therapy Production, Import, Consumption and Export (2017-2022)
-
Table North America Oncolytic Virus Therapy Sales Volume, by Type (2017-2028)
-
Table North America Oncolytic Virus Therapy Sales Volume Share, by Type (2017-2028)
-
Figure North America Oncolytic Virus Therapy Sales Volume Share, by Type (2017-2028)
-
Table North America Oncolytic Virus Therapy Sales Volume, by Application (2017-2028)
-
Table North America Oncolytic Virus Therapy Sales Volume Share, by Application (2017-2028)
-
Figure North America Oncolytic Virus Therapy Sales Volume Share, by Application (2017-2028)
-
Figure United States Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure United States Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Canada Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Table Europe Oncolytic Virus Therapy Sales Volume, by Type (2017-2028)
-
Table Europe Oncolytic Virus Therapy Sales Volume Share, by Type (2017-2028)
-
Figure Europe Oncolytic Virus Therapy Sales Volume Share, by Type (2017-2028)
-
Table Europe Oncolytic Virus Therapy Sales Volume, by Application (2017-2028)
-
Table Europe Oncolytic Virus Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Europe Oncolytic Virus Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Germany Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure UK Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure UK Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure France Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure France Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Italy Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Spain Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Poland Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Russia Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Table APAC Oncolytic Virus Therapy Sales Volume, by Type (2017-2028)
-
Table APAC Oncolytic Virus Therapy Sales Volume Share, by Type (2017-2028)
-
Figure APAC Oncolytic Virus Therapy Sales Volume Share, by Type (2017-2028)
-
Table APAC Oncolytic Virus Therapy Sales Volume, by Application (2017-2028)
-
Table APAC Oncolytic Virus Therapy Sales Volume Share, by Application (2017-2028)
-
Figure APAC Oncolytic Virus Therapy Sales Volume Share, by Application (2017-2028)
-
Figure China Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure China Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Japan Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure India Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure India Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Oncolytic Virus Therapy Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Oncolytic Virus Therapy Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Oncolytic Virus Therapy Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Oncolytic Virus Therapy Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Oncolytic Virus Therapy Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Oncolytic Virus Therapy Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Oncolytic Virus Therapy Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Oncolytic Virus Therapy Sales Value and Growth Rate (2017-2028)
-
Table Oncolytics Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Oncolytics Biotech Product Profiles, Application and Specification
-
Table Oncolytics Biotech Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table TILT Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table TILT Biotherapeutics Product Profiles, Application and Specification
-
Table TILT Biotherapeutics Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Vyriad Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Vyriad Product Profiles, Application and Specification
-
Table Vyriad Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Genelux Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Genelux Corporation Product Profiles, Application and Specification
-
Table Genelux Corporation Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Transgene SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Transgene SA Product Profiles, Application and Specification
-
Table Transgene SA Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Viralytics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Viralytics Product Profiles, Application and Specification
-
Table Viralytics Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Lokon Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Lokon Pharma Product Profiles, Application and Specification
-
Table Lokon Pharma Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Targovax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Targovax Product Profiles, Application and Specification
-
Table Targovax Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Cold Genesys Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Cold Genesys Product Profiles, Application and Specification
-
Table Cold Genesys Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table PsiOxus Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table PsiOxus Therapeutics Product Profiles, Application and Specification
-
Table PsiOxus Therapeutics Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table SillaJen Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table SillaJen Biotherapeutics Product Profiles, Application and Specification
-
Table SillaJen Biotherapeutics Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Oncolys BioPharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Oncolys BioPharma Product Profiles, Application and Specification
-
Table Oncolys BioPharma Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sorrento Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sorrento Therapeutics Product Profiles, Application and Specification
-
Table Sorrento Therapeutics Oncolytic Virus Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
